CAS: 28143-91-1; L-Threo-1-Phenyl-2-Amino-1,3-Propanediol

该化合物是一种手性二醇和氨基酒精化合物,具有明确的立体化学特性,使其成为非对称合成和制药应用中有价值的中间体,其硬性结构以氢氧基和氨基功能组为特点,能够用作对等选择性催化剂和生物活性分子的配制中的离心或构件.(1S,2S)配置确保了高立体化学纯度,这对于需要精确的手力控制的应用至关重要.该化合物在医学化学中特别有用,可以合成β-成腺受体活性活性剂和其他治疗方法.其稳定性和特性明确性能使得它成为研究和工业过程的可靠选择.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号3306-06-7 1S,2S-(+)-2-ami... | CAS号5267-64-1 D-苯丙氨醇 | CAS号51594-34-4 (1S,2S)-(+)-2-氨... | CAS号90-82-4 伪麻黄碱 | CAS号52075-14-6 (4S,5S)-(-)-4-甲... | CAS号116950-01-7 [2S-(2α,3β,8aβ)... | CAS号35019-66-0 (4S,5S)-2,2-二甲基... | CAS号2153-98-2 (1S,2S)-2-amino...

合成工艺路线路线简述

    Trans-4-(Methoxycarbonyl)-5-Phenyl-2-Oxazoline置于盐酸,Sodium Tetrahydroborate,水体系中,用 乙醇,水,异丙醇 用作溶剂,化学反应 3.0H,反应生成(1S,2S)-(+)-2-氨基-1-苯基-1,3-丙二醇
    参考文献:Schoellkopf,Ulrich; Scheunemann,Karl-Heinz,Liebigs Annalen Der Chemie,1980,# 8,P. 1348-1349
    标题:Schoellkopf,Ulrich; Scheunemann,Karl-Heinz,Liebigs Annalen Der Chemie,1980,# 8,P. 1348-1349

    海关参考信息

    专利信息


    专利号:US-5248815-A
    优先权日:1991-12-27
    标 题 :Stereo-selective synthesis of 2-aryl-propionic acids of high optical purity by using chiral oxazolines
    发明人:PARADIES HENRICH H
    权利人:PARADIES HENRICH H
    摘要:The present invention relates to a stereospecific chemical synthesis of optically pure enantiomers of 2-aryl-alkanoic acids, especially those of the biologically active (S)-aryl-propionic acids, in good chemical yields, useful for preparing large quantities thereof, and having a high optical purity.

    专利号:US-5401852-A
    优先权日:1989-10-20
    标 题:Process for the stereochemical inversion of (2S,3S)-2-amino-3-phenyl-1,3-propanediols into their (2R,3R) enantiomers
    发明人:VILLA MARCO; GIORDANO CLAUDIO; CAVICCHIOLI SILVIA; LEVI SILVIO
    权利人:ZAMBON SPA
    摘要:Intermediates for transforming (2S,3S)-2-amino-3-phenyl-1,3-propanediols into their (2R,3R)-enantiomers are described. The final compounds are useful intermediates for the synthesis of antibiotics like chloramphenicol, Thiamphenicol and Florfenicol.

    专利号:US-4939295-A
    优先权日:1988-07-26
    标 题:Process for the preparation of intermediates for the synthesis of diltiazem
    发明人:MERLI VALERIANO; SAGRAMORA GIORGIO; SORIATO GIORGIO
    权利人:ZAMBON SPA
    摘要:A process for the preparation of (2S,3S)-threo-2-hydroxy-3-(2-aminophenylthio)-3-(4-methoxyphenyl)-propionic acid by resolution of the racemic mixture is described. n The resolution is carried out by using as resolving agent (1S,2S)-threo-1-phenyl-2-amino-1,3-propanediol or (1S,2S)-threo-1-(4-methylthiophenyl)-2-amino-1,3-propanediol.

    专利号:US-8778631-B2
    优先权日:2009-01-12
    标题:Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system
    发明人:VOLOSHIN ALEXEI M; ZAWADA JAMES F; GOLD DANIEL; MURRAY CHRISTOPHER JAMES; ROZZELLE JAMES EDWARD; UTER NATHAN; YIN GANG
    权利人:VOLOSHIN ALEXEI M; ZAWADA JAMES F; GOLD DANIEL; MURRAY CHRISTOPHER JAMES; ROZZELLE JAMES EDWARD; UTER NATHAN; YIN GANG; SUTRO BIOPHARMA INC
    摘要:This invention provides for a novel means of incorporating non-native amino acids into preselected positions of a protein using a cell-free synthesis system. The methods involve the use of non-orthogonal, native isoaccepting sense tRNAs that are encoded by the genetic code. Such methods allow for numerous non-native amino acids to be incorporated through the use of sense codons without having to rely upon orthogonal tRNA-synthetase pairs.

    专利号:WO-9313046-A1
    优先权日:1991-12-27
    标题:Stereo-selective synthesis of 2-aryl-propionic acids of high optical purity by using chiral oxazolines

    专利号:US-7659244-B2
    优先权日:2003-11-03
    标题:Rapamycin peptides conjugates: synthesis and uses thereof
    发明人:SHARMA SANJAY K; WOO THOMAS; NAICKER SELVARAJ
    权利人:QUEST PHARMATECH INC
    摘要:The present invention relates to new rapamycin derivatives for the inhibition of cell proliferation. The compounds can advantageously target two proteins in dividing cells and interfere with cell cycle. There is thus provided derivatives of rapamycin in which the 42 position of rapamycin is linked to an amino acid or a peptide through a carbamate ester linkage. These rapamycin derivatives can be synthesized by reacting 42-O-(4-Nitrophenoxycarbonyl) rapamycin and an amino acid or a free amino peptide under basic conditions. These rapamycin derivatives can be used to inhibit the cell cycle and are therefore useful for treating cell proliferation disorders.
    杭州扬德医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.beyond-pharma.com
    电话: 0571-81953185👤
    📞杭州扬德医药科技有限公司 ⚠️参考联系方式

    销售电话:0571-81953185
    邮箱:sales@beyond-chemical.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:The Asymmetric Synthesis Of Amines Via Nickel-Catalyzed Enantioconvergent Substitution Reactions
    作者:Ze-Peng Yang,Dylan J. Freas,Gregory C. Fu |发布日期:2021.2.24
    摘要:Dialkyl Carbinamines Do Not Provide General Access To Amines Wherein The Two Alkyl Groups Are Of Similar Size (E.G., Ch2R Versus Ch2R1). Herein, We Report Two Mild Methods For The Catalytic Enantioconvergent Synthesis Of Protected Dialkyl Carbinamines, Both Of Which Use A Chiral Nickel Catalyst To Couple An Alkylzinc Reagent (1.1-1.2 Equiv) With A Racemic Partner, Specifically, An α-Phthalimido Alkyl Chloride

    合成参考文献


    摘要:Lubell, W. D.; St-Cyr, D. J.; Dufour-Gallant, J.; Hopewell, R.; Boutard, N.; Kassem, T.; Dörr, A.; Zelli, R., Science of Synthesis Knowledge Updates, (2013) 1, 210.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知